Col George Peoples, MD

['lizbeth]

http://www.antigenexpress.com/therapeutic_focus.html

Scroll down and it shows that the AE37 vaccine is still Phase II, so I guess approval if & when would be 5 - 6 years.

E75 is the vaccine that has reached phase III for node positive.

http://www.galenabiopharma.com/pipeline#neuvax

I think I saw 2017 as a possible approval date in an online article.

Both vaccines are switching from high expressors to low expressors of Her2. I'm a little nervous that it won't be approved for us Her2 3+. The more treatments available, the better for everyone. And I will be thrilled to see this as an option for the 3Ns that are Her2 1+ and 2+.